C.E. Wooten

Papers

Total Citations

H-Index

About

C.E. Wooten is a leading surgical oncologist whose research focuses on optimizing treatment strategies for head and neck cancers, particularly oropharynx squamous cell carcinoma. Their most-cited work, a 2019 study comparing transoral robotic surgery (TORS) to definitive chemoradiation for resectable oropharynx cancer, has garnered 40 citations and directly addresses a critical clinical dilemma: balancing oncologic efficacy with functional preservation. Wooten’s contributions have helped refine patient selection criteria for surgical versus nonsurgical approaches, demonstrating that TORS can achieve comparable survival outcomes while potentially reducing long-term toxicity. This work has shaped multidisciplinary treatment paradigms, guiding surgeons and radiation oncologists toward more personalized care. Beyond this landmark study, Wooten’s broader research portfolio explores minimally invasive surgical techniques, quality-of-life outcomes, and the integration of biomarkers into treatment decision-making. Their impact is evident in the growing adoption of TORS protocols and the ongoing debate their findings have sparked in clinical guidelines. For students and researchers, Wooten exemplifies how comparative effectiveness research can bridge surgical innovation and evidence-based practice, offering a model for translating complex clinical data into actionable treatment algorithms.